These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 12749516

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment costs of community-acquired pneumonia in an employed population.
    Colice GL, Morley MA, Asche C, Birnbaum HG.
    Chest; 2004 Jun; 125(6):2140-5. PubMed ID: 15189934
    [Abstract] [Full Text] [Related]

  • 3. Resource use and cost of care for patients hospitalised with community acquired pneumonia: impact of adherence to infectious diseases society of america guidelines.
    Orrick JJ, Segal R, Johns TE, Russell W, Wang F, Yin DD.
    Pharmacoeconomics; 2004 Jun; 22(11):751-7. PubMed ID: 15250752
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hospitalization costs for community-acquired pneumonia in Dutch elderly: an observational study.
    Vissink CE, Huijts SM, de Wit GA, Bonten MJ, Mangen MJ.
    BMC Infect Dis; 2016 Sep 02; 16(1):466. PubMed ID: 27589847
    [Abstract] [Full Text] [Related]

  • 6. Community-acquired pneumonia: economics of inpatient medical care vis-à-vis clinical severity.
    Cupurdija V, Lazic Z, Petrovic M, Mojsilovic S, Cekerevac I, Rancic N, Jakovljevic M.
    J Bras Pneumol; 2015 Sep 02; 41(1):48-57. PubMed ID: 25750674
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cost effectiveness of adherence to IDSA/ATS guidelines in elderly patients hospitalized for Community-Aquired Pneumonia.
    Egger ME, Myers JA, Arnold FW, Pass LA, Ramirez JA, Brock GN.
    BMC Med Inform Decis Mak; 2016 Mar 15; 16():34. PubMed ID: 26976388
    [Abstract] [Full Text] [Related]

  • 9. Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia.
    Menéndez R, Reyes S, Martínez R, de la Cuadra P, Manuel Vallés J, Vallterra J.
    Eur Respir J; 2007 Apr 15; 29(4):751-6. PubMed ID: 17005580
    [Abstract] [Full Text] [Related]

  • 10. The cost of treating community-acquired pneumonia.
    Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R.
    Clin Ther; 1998 Apr 15; 20(4):820-37. PubMed ID: 9737840
    [Abstract] [Full Text] [Related]

  • 11. CAPECO: Cost evaluation of community acquired pneumonia managed in primary care.
    Personne V, Chevalier J, Buffel du Vaure C, Partouche H, Gilberg S, de Pouvourville G.
    Vaccine; 2016 Apr 27; 34(19):2275-80. PubMed ID: 26979138
    [Abstract] [Full Text] [Related]

  • 12. Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort.
    Wu JH, Howard DH, McGowan JE, Turpin RS, Henry Hu X.
    Clin Ther; 2006 Sep 27; 28(9):1451-61. PubMed ID: 17062317
    [Abstract] [Full Text] [Related]

  • 13. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
    Skrepnek GH, Armstrong EP, Malone DC, Ramachandran S.
    Curr Med Res Opin; 2005 Feb 27; 21(2):261-70. PubMed ID: 15801997
    [Abstract] [Full Text] [Related]

  • 14. Burden of community-acquired pneumonia in North American adults.
    File TM, Marrie TJ.
    Postgrad Med; 2010 Mar 27; 122(2):130-41. PubMed ID: 20203464
    [Abstract] [Full Text] [Related]

  • 15. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study.
    Divino V, Schranz J, Early M, Shah H, Jiang M, DeKoven M.
    Curr Med Res Opin; 2020 Jan 27; 36(1):151-160. PubMed ID: 31566005
    [Abstract] [Full Text] [Related]

  • 16. Potential for cost-savings in the care of hospitalized low-risk community-acquired pneumonia patients in China.
    Zhou QT, He B, Zhu H.
    Value Health; 2009 Jan 27; 12(1):40-6. PubMed ID: 18637052
    [Abstract] [Full Text] [Related]

  • 17. Cost and incidence of social comorbidities in low-risk patients with community-acquired pneumonia admitted to a public hospital.
    Goss CH, Rubenfeld GD, Park DR, Sherbin VL, Goodman MS, Root RK.
    Chest; 2003 Dec 27; 124(6):2148-55. PubMed ID: 14665494
    [Abstract] [Full Text] [Related]

  • 18. Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?
    Brown PD.
    Pharmacoeconomics; 2004 Dec 27; 22(7):413-20. PubMed ID: 15137880
    [Abstract] [Full Text] [Related]

  • 19. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years.
    Sato R, Gomez Rey G, Nelson S, Pinsky B.
    Appl Health Econ Health Policy; 2013 Jun 27; 11(3):251-8. PubMed ID: 23605251
    [Abstract] [Full Text] [Related]

  • 20. Adherence to guidelines and its impact on outcomes in patients hospitalized with community-acquired pneumonia at a university hospital.
    Silveira CD, Ferreira CS, Corrêa Rde A.
    J Bras Pneumol; 2012 Jun 27; 38(2):148-57. PubMed ID: 22576421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.